
Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues), Therapy Area (Eye drops and Solutions, Gels and Ointments, Capsules and Tablets), Distribution Channel an
Description
Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues), Therapy Area (Eye drops and Solutions, Gels and Ointments, Capsules and Tablets), Distribution Channel and Segment Forecast, 2022-2027
Summary
The dry eye syndrome market size was valued at US$5,465.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% during 2022-2027. The dry eye syndrome market report provides an executive-level overview of dry eye syndrome worldwide today, with detailed forecasts of key indicators up to 2027.
This market intelligence report offers a thorough, forward-looking analysis of the global dry eye syndrome market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
Key Highlights
The dry eye syndrome market size was valued at US$5,465.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% during 2022-2027. The major factors contributing to the market growth includes, rise in ageing population, growth in eye care centers to handle the rising burden of ophthalmological disorders, increasing research and development.
Scope
Summary
The dry eye syndrome market size was valued at US$5,465.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% during 2022-2027. The dry eye syndrome market report provides an executive-level overview of dry eye syndrome worldwide today, with detailed forecasts of key indicators up to 2027.
This market intelligence report offers a thorough, forward-looking analysis of the global dry eye syndrome market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
Key Highlights
The dry eye syndrome market size was valued at US$5,465.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% during 2022-2027. The major factors contributing to the market growth includes, rise in ageing population, growth in eye care centers to handle the rising burden of ophthalmological disorders, increasing research and development.
Scope
- Overview of dry eye syndrome including industry trends, deals, and product & company profile
- dry eye syndrome market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, dosage form, distribution channel, and geographic segments.
- Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the key product segments.
- Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the dosage form segment. Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the distribution channel segment.
- The competitive landscape: an examination of the positioning of leading players in dry eye syndrome market.
- This market intelligence report offers a thorough, forward-looking analysis of the dry eye syndrome market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
- Accompanying GlobalData’s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in dry eye syndrome markets.
- The report also highlights key product, dosage form and distribution channel segments.
- With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
- The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in dry eye syndrome market.
Table of Contents
121 Pages
- Dry Eye Syndrome Market Snapshot
- Dry Eye Syndrome Market- Key Findings
- Market Definition
- Market Scope and Segmentation
- Etiology and Pathophysiology
- Epidemiological For Dry Eye Syndrome
- Diagnosis and Treatment Overview
- Cyclosporine
- LFA-1 Antagonist
- Mucin Secretagogue
- Corticosteroids
- Artificial Tears
- Autologous Serum
- Overview
- More Treatment Options with Favorable Tolerability Profiles
- Better Diagnostic Tools
- Simplified Dosing with Cost-Effective Options
- Overview
- Late-Stage Pipeline Products
- Dry Eye Syndrome Market Structure - PORTER's Analysis
- Product Launches in Dry Eye Syndrome
- Important Milestones in Dry Eye Syndrome
- Global Dry Eye Syndrome Market
- Dry Eye Syndrome - Product Dive
- Dry Eye Syndrome -Dosage Form Dive
- Fig.28 Dry Eye Syndrome by Distribution Channel - Market Overview ($Mn)
- Fig.29 Dry Eye Syndrome by Distribution Channel Share - 2021 & 2027 (%)
- Dry Eye Syndrome by Distribution Channel, 2020-2027 ($Mn)
- HOSPITAL PHARMACY
- Dry Eye Syndrome - Regional Deep Dive
- Dry Eye Syndrome - Market Trends
- Dry Eye Syndrome - Market Drivers
- Dry Eye Syndrome - Market Challenges
- Dry Eye Syndrome - Market Opportunities
- Allergan
- Aldeyra Therapeutics
- Aurinia Pharmaceuticals
- Kala Pharmaceuticals
- Mitotech
- Novartis
- RegeneRX Biopharmaceuticals/ReGenTree
- Sun Pharmaceutical
- HEAT MAP ANALYSIS
- COMPANY SNAPSHOT: NOVARTIS AG
- Methodology
- About US
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.